332 related articles for article (PubMed ID: 30764633)
21. Synchronous glioblastoma and medulloblastoma in a child with mismatch repair mutation.
Amayiri N; Al-Hussaini M; Swaidan M; Jaradat I; Qandeel M; Tabori U; Hawkins C; Musharbash A; Alsaad K; Bouffet E
Childs Nerv Syst; 2016 Mar; 32(3):553-7. PubMed ID: 26293676
[TBL] [Abstract][Full Text] [Related]
22. Non-Small Cell Lung Cancer with Estrogen Receptors and ALK Positivity.
Žarnayová L; Kolek V; Bouchal J; Ehrmann J
Klin Onkol; 2018; 31(6):457-460. PubMed ID: 31035769
[TBL] [Abstract][Full Text] [Related]
23. Durable Response to Nivolumab in a Pediatric Patient with Refractory Glioblastoma and Constitutional Biallelic Mismatch Repair Deficiency.
AlHarbi M; Ali Mobark N; AlMubarak L; Aljelaify R; AlSaeed M; Almutairi A; Alqubaishi F; Hussain ME; Balbaid AAO; Said Marie A; AlSubaie L; AlShieban S; alTassan N; Ramkissoon SH; Abedalthagafi M
Oncologist; 2018 Dec; 23(12):1401-1406. PubMed ID: 30104292
[TBL] [Abstract][Full Text] [Related]
24. Recommendations on surveillance and management of biallelic mismatch repair deficiency (BMMRD) syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer.
Durno C; Boland CR; Cohen S; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Levin TR; Lieberman D; Robertson DJ; Rex DK
Gastrointest Endosc; 2017 May; 85(5):873-882. PubMed ID: 28363411
[No Abstract] [Full Text] [Related]
25. [Constitutional mismatch repair deficiency syndrome].
Jongmans MC; Gidding CE; Loeffen J; Wesseling P; Mensenkamp A; Hoogerbrugge N
Ned Tijdschr Geneeskd; 2015; 159():A8602. PubMed ID: 26200421
[TBL] [Abstract][Full Text] [Related]
26. DICER1 Syndrome.
Hořínová V; Drábová K; Nosková H; Bajčiová V; Šoukalová J; Černá L; Hůrková V; Slabý O; Štěrba J
Klin Onkol; 2019; 32(Supplementum2):123-127. PubMed ID: 31409088
[TBL] [Abstract][Full Text] [Related]
27. Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium "Care for CMMR-D" (C4CMMR-D).
Vasen HF; Ghorbanoghli Z; Bourdeaut F; Cabaret O; Caron O; Duval A; Entz-Werle N; Goldberg Y; Ilencikova D; Kratz CP; Lavoine N; Loeffen J; Menko FH; Muleris M; Sebille G; Colas C; Burkhardt B; Brugieres L; Wimmer K;
J Med Genet; 2014 May; 51(5):283-93. PubMed ID: 24556086
[TBL] [Abstract][Full Text] [Related]
28. [A Patient with Primary Intraventricular Gliosarcoma and Long-term Survival - a Case Report].
Kalita O; Zlevorová M; Megová M; Vaverka M; Trojanec R; Tučková L
Klin Onkol; 2016; 29(6):454-459. PubMed ID: 27951723
[TBL] [Abstract][Full Text] [Related]
29. Rare Hereditary Burden associated with a Hypercalcemic Small-Cell Carcinoma of Cervix in a Young Female Patient.
Hruška L; Sirák I; Laco J; Fridrichová P; Nosková H; Slabý O; Pál K; Bočkayová V; Hodek M; Petera J
Klin Onkol; 2019; 32(6):456-462. PubMed ID: 31842565
[TBL] [Abstract][Full Text] [Related]
30. Frequency of mismatch repair protein deficiency and PD-L1 in high-grade gliomas in adolescents and young adults (AYA).
Almuhaisen G; Alhalaseh Y; Mansour R; Abu-Shanab A; Al-Ghnimat S; Al-Hussaini M
Brain Tumor Pathol; 2021 Jan; 38(1):14-22. PubMed ID: 32897465
[TBL] [Abstract][Full Text] [Related]
31. Pitfalls in molecular analysis for mismatch repair deficiency in a family with biallelic pms2 germline mutations.
Leenen CH; Geurts-Giele WR; Dubbink HJ; Reddingius R; van den Ouweland AM; Tops CM; van de Klift HM; Kuipers EJ; van Leerdam ME; Dinjens WN; Wagner A
Clin Genet; 2011 Dec; 80(6):558-65. PubMed ID: 21204794
[TBL] [Abstract][Full Text] [Related]
32. Molecular Profiling of Pediatric and Adult Glioblastoma.
Gestrich CK; Jajosky AN; Elliott R; Stearns D; Sadri N; Cohen ML; Couce ME
Am J Clin Pathol; 2021 Mar; 155(4):606-614. PubMed ID: 33210143
[TBL] [Abstract][Full Text] [Related]
33. Clinical Management and Tumor Surveillance Recommendations of Inherited Mismatch Repair Deficiency in Childhood.
Tabori U; Hansford JR; Achatz MI; Kratz CP; Plon SE; Frebourg T; Brugières L
Clin Cancer Res; 2017 Jun; 23(11):e32-e37. PubMed ID: 28572265
[TBL] [Abstract][Full Text] [Related]
34. [Immunotherapy of Renal Cell Carcinoma].
Poprach A; Lakomý R; Büchler T
Klin Onkol; 2017; 30(Supplementum3):55-61. PubMed ID: 29239194
[TBL] [Abstract][Full Text] [Related]
35. The great mimicker: Phenotypic overlap between constitutional mismatch repair deficiency and Tuberous Sclerosis complex.
Shapira Rootman M; Goldberg Y; Cohen R; Kropach N; Keidar I; Friedland R; Dotan G; Konen O; Toledano H
Clin Genet; 2020 Feb; 97(2):296-304. PubMed ID: 31730237
[TBL] [Abstract][Full Text] [Related]
36. [Constitutional mismatch repair-deficiency syndrome (CMMR-D) - a case report of a family with biallelic MSH6 mutation].
Ilenčíková D
Klin Onkol; 2012; 25 Suppl():S34-8. PubMed ID: 22920205
[TBL] [Abstract][Full Text] [Related]
37. Delineating a new feature of constitutional mismatch repair deficiency (CMMRD) syndrome: breast cancer.
Bush L; Aronson M; Tabori U; Campbell BB; Bedgood RB; Jasperson K
Fam Cancer; 2019 Jan; 18(1):105-108. PubMed ID: 29785566
[TBL] [Abstract][Full Text] [Related]
38. Hypermutation as a potential predictive biomarker of immunotherapy efficacy in high-grade gliomas: a broken dream?
Gatto L; Franceschi E; Tosoni A; Nunno VD; Bartolini S; Brandes AA
Immunotherapy; 2022 Jul; 14(10):799-813. PubMed ID: 35670093
[TBL] [Abstract][Full Text] [Related]
39. Hypermutated Tumors and Immune Checkpoint Inhibition.
Ciombor KK; Goldberg RM
Drugs; 2018 Feb; 78(2):155-162. PubMed ID: 29350327
[TBL] [Abstract][Full Text] [Related]
40. [Constitutional MMR deficiency: Genetic bases and clinical implications].
Buecher B; Le Mentec M; Doz F; Bourdeaut F; Gauthier-Villars M; Stoppa-Lyonnet D; Colas C
Bull Cancer; 2019 Feb; 106(2):162-172. PubMed ID: 30551794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
